Molecular Pathogenesis of Ehrlichia chaffeensis Infection

Annual Review of Microbiology

Volumn 69, Issue 1, 2015, Pages 283-304

  Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Adhesin; Chemokines; Cytokines; Invasin; MyD88; Outer membrane proteins; Receptor for entry; Two component system; Type I and IV secretion systems

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; GAMMA INTERFERON; INVASIN; OMP 1F PROTEIN; PROTEIN P28; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; TYPE IV SECRETION SYSTEM;

APOPTOSIS; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CELL COMPARTMENTALIZATION; DOWN REGULATION; GENE REPLICATION; HOST CELL; HUMAN; HUMAN MONOCYTIC EHRLICHIOSIS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TYPE IV SECRETION SYSTEM; ANIMAL; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; HUMANS; INFLAMMATION; LEUKOCYTES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TYPE IV SECRETION SYSTEMS;

EID: 84945255271     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-091014-104411     Document Type: Article

References (150)

1. Alvarez-Martinez CE, Christie PJ. 2009. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73: 775-808
2. Anderson BE, Dawson JE, Jones DC, Wilson KH. 1991. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 29: 2838-42
3. Anderson BE, SimsKG, Olson JG, Childs JE, Piesman JF, et al. 1993. Amblyomma americanum: A potential vector of human ehrlichiosis. Am. J. Trop. Med. Hyg. 49: 239-44
4. Andersson M, Raberg L. 2011. Wild rodents and novel human pathogen Candidatus Neoehrlichia mikurensis, Southern Sweden. Emerg. Infect. Dis. 17: 1716-18
5. Andersson SG, Zomorodipour A, Andersson JO, Sicheritz-Ponten T, Alsmark UC, et al. 1998. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396: 133-40
6. BaoW, Kumagai Y, Niu H, Yamaguchi M, Miura K, Rikihisa Y. 2009. Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. J. Bacteriol. 191: 278-86
7. Barnewall RE, Ohashi N, Rikihisa Y. 1999. Ehrlichia chaffeensis and E. Sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect. Immun. 67: 2258-65
8. Barnewall RE, Rikihisa Y. 1994. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect. Immun. 62: 4804-10
9. Barnewall RE, Rikihisa Y, Lee EH. 1997. Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect. Immun. 65: 1455-61
10. Bitsaktsis C, Huntington J, Winslow G. 2004. Production of IFN-by CD4 T cells is essential for resolving ehrlichia infection. J. Immunol. 172: 6894-901
11. Bitsaktsis C, Nandi B, Racine R, MacNamara KC, Winslow G. 2007. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection. Infect. Immun. 75: 4933-41
12. Bitsaktsis C, Winslow G. 2006. Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection. J. Immunol. 177: 4644-51
13. BullerRS, ArensM, Hmiel SP, PaddockCD, Sumner JW, et al. 1999. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N. Engl. J. Med. 341: 148-55
14. CDC. 2013. Notifiable Diseases and Mortality Tables. Morb. Mortal. Wkly. Rep. 62: ND-695
15. Chen SM, Cullman LC, Walker DH. 1997. Western immunoblotting analysis of the antibody responses of patients with humanmonocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis. Clin. Diagn. Lab. Immunol. 4: 731-35
16. Chen SM, Dumler JS, Bakken JS, Walker DH. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32: 589-95
17. ChengC, Nair AD, Indukuri VV, Gong S, Felsheim RF, et al. 2013. Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. PLOS Pathog. 9: e1003171
18. Cheng C, Paddock CD, Reddy Ganta R. 2003. Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. Infect. Immun. 71: 187-95
19. Cheng Y, Liu Y, Wu B, Zhang JZ, Gu J, et al. 2014. Proteomic analysis of the Ehrlichia chaffeensis phagosome in cultured DH82 cells. PLOS ONE 9: e88461
20. Cheng Z, Kumagai Y, LinM, Zhang C, Rikihisa Y. 2006. Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. Cell. Microbiol. 8: 1241-52
21. Cheng Z, Lin M, Rikihisa Y. 2014. Ehrlichia chaffeensis proliferation begins with NtrY/NtrX and PutA/GlnA upregulation and CtrA degradation induced by proline and glutamine uptake. mBio 5: e02141-14
22. Cheng Z, Miura K, Popov VL, Kumagai Y, Rikihisa Y. 2011. Insights into the CtrA regulon in development of stress resistance in obligatory intracellular pathogen Ehrlichia chaffeensis. Mol Microbiol. 82: 1217-34
23. Cheng Z, Wang X, Rikihisa Y. 2008. Regulation of type IV secretion apparatus genes during Ehrlichia chaffeensis intracellular development by a previously unidentified protein. J. Bacteriol. 190: 2096-105
24. Cohen MS. 1994. Molecular events in the activation of human neutrophils for microbial killing. Clin. Infect. Dis. 18(Suppl. 2): S170-79
25. Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, et al. 1991. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J. Clin. Microbiol. 29: 2741-45
26. Dawson JE, Ewing SA. 1992. Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am. J. Vet. Res. 53: 1322-27
27. DeLeo FR. 2004. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 9: 399-413
28. Doyle CK, Nethery KA, Popov VL, McBride JW. 2006. Differentially expressed and secreted major immunoreactive protein orthologs of Ehrlichia canis and E. Chaffeensis elicit early antibody responses to epitopes on glycosylated tandem repeats. Infect. Immun. 74: 711-20
29. DuganVG, Little SE, StallknechtDE, Beall AD. 2000. Natural infection of domestic goats with Ehrlichia chaffeensis. J. Clin. Microbiol. 38: 448-49
30. Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, et al. 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51: 2145-65
31. Dumler JS, Chen SM, Asanovich K, Trigiani E, Popov VL, Walker DH. 1995. Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis. J. Clin. Microbiol. 33: 1704-11
32. Dunning Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuoli SV, et al. 2006. Comparative genomics of emerging human ehrlichiosis agents. PLOS Genet. 2: e21
33. Dunphy PS, Luo T, McBride JW. 2014. Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival. Infect. Immun. 82: 4154-68
34. Ewing SA, Dawson JE, Kocan AA, Barker RW, Warner CK, et al. 1995. Experimental transmission of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) among white-tailed deer by Amblyomma americanum (Acari: Ixodidae). J. Med. Entomol. 32: 368-74
35. Fehr JS, Bloemberg GV, RitterC, Hombach M, Luscher TF, et al. 2010. Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerg. Infect. Dis. 16: 1127-29
36. Felek S, Unver A, Stich RW, Rikihisa Y. 2001. Sensitive detection of Ehrlichia chaffeensis in cell culture, blood, and tick specimens by reverse transcription-PCR. J. Clin. Microbiol. 39: 460-63
37. Fujita H, Watanabe Y. 1994. Ehrlichial organisms isolated from Ixodes ovatus ticks and field rodents in Japan. Ann. Rep. Ohara Hosp. 37: 13-17
38. Ganta RR, Cheng C, Miller EC, McGuire BL, Peddireddi L, et al. 2007. Differential clearance and immune responses to tick cell-derived versus macrophage culture-derived Ehrlichia chaffeensis in mice. Infect. Immun. 75: 135-45
39. Ganta RR, ChengC, WilkersonMJ, Chapes SK. 2004. Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice. Infect. Immun. 72: 159-67
40. Gardner SL, Holman RC, Krebs JW, Berkelman R, Childs JE. 2003. National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. Ann. N. Y. Acad. Sci. 990: 80-89
41. Ge Y, Rikihisa Y. 2006. Anaplasma phagocytophilum delays spontaneous human neutrophil apoptosis by modulation of multiple apoptotic pathways. Cell. Microbiol. 8: 1406-16
42. Ge Y, Rikihisa Y. 2007. Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J. Bacteriol. 189: 7819-28
43. Ge Y, Rikihisa Y. 2007. Surface-exposed proteins of Ehrlichia chaffeensis. Infect. Immun. 75: 3833-41
44. Ge Y, Yoshiie K, Kuribayashi F, Lin M, Rikihisa Y. 2005. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell. Microbiol. 7: 29-38
45. Gentle IE, Burri L, Lithgow T. 2005. Molecular architecture and function of the Omp85 family of proteins. Mol. Microbiol. 58: 1216-25
46. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, et al. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334: 209-15
47. Hackstadt T, Baehr W, Ying Y. 1991. Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. PNAS 88: 3937-41
48. Hallez R, Bellefontaine AF, Letesson JJ, De Bolle X. 2004. Morphological and functional asymmetry in alpha-proteobacteria. Trends Microbiol. 12: 361-65
49. Heinzen RA, Hackstadt T. 1996. A developmental stage-specific histone H1 homolog of Coxiella burnetii. J. Bacteriol. 178: 5049-52
50. Holley AK, Dhar SK, Xu Y, St Clair DK. 2012. Manganese superoxide dismutase: beyond life and death. Amino Acids 42: 139-58
51. Huang H, Lin M, Wang X, Kikuchi T, Mottaz H, et al. 2008. Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. Infect. Immun. 76: 3405-14
52. Hubber A, Arasaki K, Nakatsu F, Hardiman C, Lambright D, et al. 2014. Themachinery at endoplasmic reticulum-plasma membrane contact sites contributes to spatial regulation of multiple Legionella effector proteins. PLOS Pathog. 10: e1004222
53. Ismail N, Bloch KC, McBride JW. 2010. Humanehrlichiosis and anaplasmosis. Clin. Lab. Med. 30: 261-92
54. Ismail N, Soong L, McBride JW, Valbuena G, Olano JP, et al. 2004. Overproduction of TNF-by CD8+ type 1 cells and down-regulation of IFN-production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J. Immunol. 172: 1786-800
55. Ismail N, Stevenson HL, Walker DH. 2006. Role of tumor necrosis factor alpha (TNF-) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55-and p75-deficient mice to fatal ehrlichial infection. Infect. Immun. 74: 1846-56
56. Ismail N, Walker DH. 2005. Balancing protective immunity and immunopathology: A unifying model of monocytotropic ehrlichiosis. Ann. N. Y. Acad. Sci. 1063: 383-94
57. Kawahara M, Suto C, Rikihisa Y, Yamamoto S, Tsuboi Y. 1993. Characterization of ehrlichial organisms isolated from a wild mouse. J. Clin. Microbiol. 31: 89-96
58. Kawahara M, Suto C, Shibata S, FutohashiM, Rikihisa Y. 1996. Impaired antigen specific responses and enhanced polyclonal stimulation in mice infected with Ehrlichia muris. Microbiol. Immunol. 40: 575-81
59. KohYS, Koo JE, Biswas A, KobayashiKS. 2010. MyD88-dependent signaling contributes to host defense against ehrlichial infection. PLOS ONE 5: e11758
60. Kumagai Y, Cheng Z, LinM, Rikihisa Y. 2006. Biochemical activities of three pairs of Ehrlichia chaffeensis two-component regulatory system proteins involved in inhibition of lysosomal fusion. Infect. Immun. 74: 5014-22
61. Kumagai Y, Huang H, Rikihisa Y. 2008. Expression and porin activity of P28 and OMP-1F during intracellular Ehrlichia chaffeensis development. J. Bacteriol. 190: 3597-605
62. Kumagai Y, Matsuo J, Cheng Z, Hayakawa Y, Rikihisa Y. 2011. Cyclic dimeric GMP signaling regulates intracellular aggregation, sessility, and growth of Ehrlichia chaffeensis. Infect. Immun. 79: 3905-12
63. Kumagai Y, Matsuo J, Hayakawa Y, Rikihisa Y. 2010. Cyclic di-GMP signaling regulates invasion by Ehrlichia chaffeensis of human monocytes. J. Bacteriol. 192: 4122-33
64. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388: 621-25
65. Kuriakose JA, Miyashiro S, Luo T, Zhu B, McBride JW. 2011. Ehrlichia chaffeensis transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation. PLOS ONE 6: e24136
66. Kuriakose JA, Zhang X, Luo T, McBride JW. 2012. Molecular basis of antibody mediated immunity against Ehrlichia chaffeensis involves species-specific linear epitopes in tandem repeat proteins. Microbes Infect. 14: 1054-63
67. Lee EH, Rikihisa Y. 1997. Anti-Ehrlichia chaffeensis antibody complexed with E. Chaffeensis induces potent proinflammatory cytokinemRNAexpression in humanmonocytes through sustained reduction of IB-and activation of NF-B. Infect. Immun. 65: 2890-97
68. Lee EH, Rikihisa Y. 1998. Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis. Infect. Immun. 66: 2514-20
69. Li H, Jiang JF, LiuW, Zheng YC, Huo QB, et al. 2012. Human infection with Candidatus Neoehrlichia mikurensis, China. Emerg. Infect. Dis. 18: 1636-39
70. Li JS, Chu F, Reilly A, WinslowGM. 2002. Antibodies highly effective in SCIDmice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization. J. Immunol. 169: 1419-25
71. Li JS, Yager E, Reilly M, Freeman C, Reddy GR, et al. 2001. Outer membrane protein-specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis. J. Immunol. 166: 1855-62
72. Ligr M, Madeo F, Frohlich E, Hilt W, Frohlich KU, WolfDH. 1998. Mammalian Bax triggers apoptotic changes in yeast. FEBS Lett. 438: 61-65
73. Lin M, den Dulk-Ras A, Hooykaas PJ, Rikihisa Y. 2007. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol. 9: 2644-57
74. LinM, Rikihisa Y. 2003. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 71: 5324-31
75. LinM, RikihisaY. 2003. Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell. Microbiol. 5: 809-20
76. Lin M, Rikihisa Y. 2004. Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU. 1 and inhibits lipopolysaccharide activation ofNF-B, ERK 1/2 and p38MAPK in host monocytes. Cell. Microbiol. 6: 175-86
77. Lin M, Rikihisa Y. 2007. Degradation of p22phox and inhibition of superoxide generation by Ehrlichia chaffeensis in human monocytes. Cell. Microbiol. 9: 861-74
78. Lin M, Zhu MX, Rikihisa Y. 2002. Rapid activation of protein tyrosine kinase and phospholipase C-2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect. Immun. 70: 889-98
79. Liu H, Bao W, Lin M, Niu H, Rikihisa Y. 2012. Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating hostMnSOD. Cell. Microbiol. 14: 1037-50
80. Liu Y, Zhang Z, Jiang Y, Zhang L, Popov VL, et al. 2011. Obligate intracellular bacterium Ehrlichia inhibiting mitochondrial activity. Microbes Infect. 13: 232-38
81. Lockhart JM, Davidson WR, Stallknecht DE, Dawson JE, Howerth EW. 1997. Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts. J. Clin. Microbiol. 35: 1681-86
82. Long SW, Zhang XF, Qi H, Standaert S, Walker DH, Yu XJ. 2002. Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect. Immun. 70: 1824-31
83. Luo T, Kuriakose JA, Zhu B, Wakeel A, McBride JW. 2011. Ehrlichia chaffeensis TRP120 interacts with a diverse array of eukaryotic proteins involved in transcription, signaling, and cytoskeleton organization. Infect. Immun. 79: 4382-91
84. Luo T, McBride JW. 2012. Ehrlichia chaffeensis TRP32 interacts with host cell targets that influence intracellular survival. Infect. Immun. 80: 2297-306
85. Luo T, Zhang X, McBride JW. 2009. Major species-specific antibody epitopes of the Ehrlichia chaffeensis p120 and E. Canis p140 orthologs in surface-exposed tandem repeat regions. Clin. Vaccine Immunol. 16: 982-90
86. Luo T, Zhang X, Wakeel A, Popov VL, McBride JW. 2008. A variable-length PCR target protein of Ehrlichia chaffeensis containsmajor species-specific antibody epitopes in acidic serine-rich tandem repeats. Infect. Immun. 76: 1572-80
87. MaedaK, Markowitz N, Hawley RC, RisticM, Cox D, McDade JE. 1987. Humaninfection with Ehrlichia canis, a leukocytic rickettsia. N. Engl. J. Med. 316: 853-56
88. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-29
89. McBride JW, Yu XJ, Walker DH. 2000. Glycosylation of homologous immunodominant proteins of Ehrlichia chaffeensis and Ehrlichia canis. Infect. Immun. 68: 13-18
90. Miura K, Matsuo J, RahmanMA, Kumagai Y, Li X, Rikihisa Y. 2011. Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-B but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or Toll-like receptors. Infect. Immun. 79: 4947-56
91. MiuraK, RikihisaY. 2007. Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect. Immun. 75: 3604-13
92. MiuraK, RikihisaY. 2009. Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensisinduced hepatitis in SCID mice. Infect. Immun. 77: 245-54
93. Mohan Kumar D, Yamaguchi M, Miura K, Lin M, Los M, et al. 2013. Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells. PLOS Pathog. 9: e1003666
94. Mott J, Barnewall RE, Rikihisa Y. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67: 1368-78
95. Niu H, Kozjak-Pavlovic V, Rudel T, Rikihisa Y. 2010. Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLOS Pathog. 6: e1000774
96. Niu H, Rikihisa Y. 2013. Ats-1: A novel bacterial molecule that links autophagy to bacterial nutrition. Autophagy 9: 787-88
97. Niu H, Rikihisa Y, Yamaguchi M, Ohashi N. 2006. Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell. Microbiol. 8: 523-34
98. Ohashi N, Rikihisa Y, Unver A. 2001. Analysis of transcriptionally active gene clusters of major outer membrane protein multigene family in Ehrlichia canis and E. Chaffeensis. Infect. Immun. 69: 2083-91
99. Ohashi N, Unver A, Zhi N, Rikihisa Y. 1998. Cloning and characterization of multigenes encoding the immunodominant 30-kilodalton major outer membrane proteins of Ehrlichia canis and application of the recombinant protein for serodiagnosis. J. Clin. Microbiol. 36: 2671-80
100. Ohashi N, Zhi N, Lin Q, Rikihisa Y. 2002. Characterization and transcriptional analysis of gene clusters for a type IVsecretion machinery in human granulocytic and monocytic ehrlichiosis agents. Infect. Immun. 70: 2128-38
101. Ohashi N, Zhi N, Zhang Y, Rikihisa Y. 1998. Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infect. Immun. 66: 132-39
102. Okada H, Tajima T, Kawahara M, Rikihisa Y. 2001. Ehrlichial proliferation and acute hepatocellular necrosis in immunocompetent mice experimentally infected with the HF strain of Ehrlichia, closely related to Ehrlichia chaffeensis. J. Comp. Pathol. 124: 165-71
103. Okada H, Usuda H, Tajima T, Kawahara M, Yoshino T, Rikihisa Y. 2003. Distribution of ehrlichiae in tissues as determined by in-situ hybridization. J. Comp. Pathol. 128: 182-87
104. Paddock CD, Childs JE. 2003. Ehrlichia chaffeensis: A prototypical emerging pathogen. Clin. Microbiol. Rev. 16: 37-64
105. Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, et al. 1997. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J. Clin. Microbiol. 35: 2496-502
106. Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y. 2006. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann. N. Y. Acad. Sci. 1078: 110-17
107. PerezM, Rikihisa Y, Wen B. 1996. Ehrlichia canis-like agent isolated from a man in Venezuela: Antigenic and genetic characterization. J. Clin. Microbiol. 34: 2133-39
108. Popov VL, Chen SM, Feng HM, Walker DH. 1995. Ultrastructural variation of cultured Ehrlichia chaffeensis. J. Med. Microbiol. 43: 411-21
109. Popov VL, Yu X, Walker DH. 2000. The 120 kDa outer membrane protein of Ehrlichia chaffeensis: Preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry. Microb. Pathog. 28: 71-80
110. Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz SM, et al. 2011. Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N. Engl. J. Med. 365: 422-29
111. Rahman MA, Cheng Z, Matsuo J, Rikihisa Y. 2012. Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway. J. Infect. Dis. 206: 110-16
112. Rikihisa Y. 1991. The tribe Ehrlichieae and ehrlichial diseases. Clin. Microbiol. Rev. 4: 286-308
113. Rikihisa Y. 2003. Mechanisms to create a safe haven by members of the family Anaplasmataceae. Ann. N. Y. Acad. Sci. 990: 548-55
114. Rikihisa Y, Lin M. 2010. Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins. Curr. Opin. Microbiol. 13: 59-66
115. Shibata S, Kawahara M, Rikihisa Y, Fujita H, Watanabe Y, et al. 2000. New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J. Clin. Microbiol. 38: 1331-38
116. Singu V, Liu H, Cheng C, Ganta RR. 2005. Ehrlichia chaffeensis expresses macrophage-and tick cellspecific 28-kilodalton outer membrane proteins. Infect. Immun. 73: 79-87
117. Standaert SM, Yu T, ScottMA, Childs JE, Paddock CD, et al. 2000. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical andmolecular characteristics. J. Infect. Dis. 181: 1082-88
118. Stevenson HL, Estes MD, Thirumalapura NR, Walker DH, Ismail N. 2010. Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am. J. Pathol. 177(2): 766-76
119. Sumimoto H. 2008. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 275: 3249-77
120. Sumner JW, Childs JE, Paddock CD. 1999. Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: An antigen-expressing gene that exhibits interstrain variation. J. Clin. Microbiol. 37: 1447-53
121. Thomas S, Popov VL, Walker DH. 2010. Exit mechanisms of the intracellular bacterium Ehrlichia. PLOS ONE 5: e15775
122. Thomas S, Thirumalapura NR, Crocquet-Valdes PA, Luxon BA, Walker DH. 2011. Structure-based vaccines provide protection in a mouse model of ehrlichiosis. PLOS ONE 6: e27981
123. Unver A, Felek S, Paddock CD, Zhi N, Horowitz HW, et al. 2001. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J. Clin. Microbiol. 39: 3982-86
124. Unver A, Huang H, Rikihisa Y. 2006. Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis. Ann. N. Y. Acad. Sci. 1078: 482-86
125. Unver A, Ohashi N, Tajima T, Stich RW, Grover D, Rikihisa Y. 2001. Transcriptional analysis of p30 major outer membrane multigene family of Ehrlichia canis in dogs, ticks, and cell culture at different temperatures. Infect. Immun. 69: 6172-78
126. Unver A, Rikihisa Y, Ohashi N, Cullman LC, Buller R, Storch GA. 1999. Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and-negative human sera by using native and recombinant E. Chaffeensis and E. Canis antigens. J. Clin. Microbiol. 37: 3888-95
127. Unver A, Rikihisa Y, Stich RW, Ohashi N, Felek S. 2002. The omp-1 major outer membrane multigene family of Ehrlichia chaffeensis is differentially expressed in canine and tick hosts. Infect. Immun. 70: 4701-704
128. van Heerden H, Collins NE, Brayton KA, Rademeyer C, Allsopp BA. 2004. Characterization of a major outer membrane protein multigene family in Ehrlichia ruminantium. Gene 330: 159-68
129. Varela AS, StallknechtDE, YabsleyMJ, MooreVA 4th, HowerthEW, et al. 2005. Primary and secondary infection with Ehrlichia chaffeensis in white-tailed deer (Odocoileus virginianus). Vector Borne Zoonotic Dis. 5: 48-57
130. Vergunst AC, van Lier MCM, den Dulk-Ras A, Grosse Stuve TA, Ouwehand A, Hooykaas PJJ. 2005. Positive charge is an important feature of the C-terminal transport signal of the VirB/D4-translocated proteins of Agrobacterium. PNAS 102: 832-37
131. von Loewenich FD, GeissdorferW, Disque C, Matten J, Schett G, et al. 2010. Detection of "Candidatus Neoehrlichia mikurensis" in two patients with severe febrile illnesses: evidence for a European sequence variant. J. Clin. Microbiol. 48: 2630-35
132. Voulhoux R, Bos MP, Geurtsen J, Mols M, Tommassen J. 2003. Role of a highly conserved bacterial protein in outer membrane protein assembly. Science 299: 262-65
133. Wakeel A, denDulk-Ras A, Hooykaas PJ, McBride JW. 2011. Ehrlichia chaffeensis tandem repeat proteins and Ank200 are type 1 secretion system substrates related to the repeats-in-toxin exoprotein family. Front. Cell. Infect. Microbiol. 1: 22
134. Wakeel A, Kuriakose JA, McBride JW. 2009. An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking. Infect. Immun. 77: 1734-45
135. Wakeel A, Zhu B, Yu XJ, McBride JW. 2010. New insights into molecular Ehrlichia chaffeensis-host interactions. Microbes Infect. 12: 337-45
136. Walker DH, Dumler JS. 1996. Emergence of the ehrlichioses as human health problems. Emerg. Infect. Dis. 2: 18-29
137. Welinder-Olsson C, Kjellin E, Vaht K, Jacobsson S, Wenneras C. 2010. First case of human "Candidatus Neoehrlichia mikurensis" infection in a febrile patient with chronic lymphocytic leukemia. J. Clin. Microbiol. 48: 1956-59
138. Wells MY, Rikihisa Y. 1988. Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: Abrogation of inhibition with oxytetracycline. Infect. Immun. 56: 3209-15
139. Wen B, Rikihisa Y, Mott J, Fuerst PA, Kawahara M, Suto C. 1995. Ehrlichia muris sp. Nov. , identified on the basis of 16S rRNA base sequences and serological, morphological, and biological characteristics. Int. J. Syst. Bacteriol. 45: 250-54
140. Winslow GM, Yager E, Shilo K, Collins DN, Chu FK. 1998. Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect. Immun. 66: 3892-99
141. Winslow GM, Yager E, Shilo K, Volk E, Reilly A, Chu FK. 2000. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect. Immun. 68: 2187-95
142. Xiong Q, Bao W, Ge Y, Rikihisa Y. 2008. Ehrlichia ewingii infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria. J. Infect. Dis. 197: 1110-18
143. Yager E, Bitsaktsis C, Nandi B, McBride JW, Winslow G. 2005. Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice. Infect. Immun. 73: 8009-16
144. Yu XJ, Crocquet-Valdes P, Cullman LC, Walker DH. 1996. The recombinant 120-kilodalton protein of Ehrlichia chaffeensis, a potential diagnostic tool. J. Clin. Microbiol. 34: 2853-55
145. Yu XJ, McBride JW, Walker DH. 1999. Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis. J. Clin. Microbiol. 37: 1137-43
146. ZhangC, Xiong Q, KikuchiT, Rikihisa Y. 2008. Identification of 19 polymorphic major outer membrane protein genes and their immunogenic peptides in Ehrlichia ewingii for use in a serodiagnostic assay. Clin. Vaccine Immunol. 15: 402-11
147. Zhang JZ, Guo H, Winslow GM, Yu XJ. 2004. Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect. Immun. 72: 4336-43
148. Zhang JZ, Popov VL, Gao S, Walker DH, Yu XJ. 2007. The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell. Microbiol. 9: 610-18
149. Zhu B, Kuriakose JA, Luo T, Ballesteros E, Gupta S, et al. 2011. Ehrlichia chaffeensis TRP120 binds a G+C-rich motif in host cell DNA and exhibits eukaryotic transcriptional activator function. Infect. Immun. 79: 4370-81
150. Zhu B, Nethery KA, Kuriakose JA, Wakeel A, Zhang X, McBride JW. 2009. Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with a specific adenine-rich motif of host promoter and intronic Alu elements. Infect. Immun. 77: 4243-55